Stock Events

Chunghwa Chemical Synthesis 

TWD50.4
2
+TWD0+0% Tuesday 05:30

Statistics

Day High
51
Day Low
50.1
52W High
102.5
52W Low
48.9
Volume
395,432
Avg. Volume
364,604
Mkt Cap
3.92B
P/E Ratio
13.65
Dividend Yield
2.58%
Dividend
1.3

Upcoming

Dividends

2.58%Dividend Yield
10Y Growth
2.66%
5Y Growth
1.61%
3Y Growth
-4.66%
1Y Growth
N/A

Earnings

29MarExpected
Q3 2021
Q1 2022
Q2 2022
Q3 2022
Q2 2023
Q3 2023
Next
1.09
1.42
1.76
2.09
Expected EPS
1.27
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 1762.TW. It's not an investment recommendation.

About

Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (APIs) in Taiwan and the United States. It offers API products, which include immunosuppressant, oncology, anti-virus, immunomodulating agents, and other products, as well as peptide drugs. The company also develops bulk pharmaceutical products, such as anti-anxiety agents, antidiabetics, laxatives, antifungals, antihistamines, antiseptics, antiulcerants, cardiovascular drugs, skeletal, muscle relaxants, hypolipaemics, antineoplastic, antihyperlipedemias, and immunosuppressant products, as well as provides research and development, and contract manufacturing services to new drug developers and generic drug companies. The company was formerly known as China Chemical Synthesis Industry Co., Ltd. Chunghwa Chemical Synthesis & Biotech Co., Ltd. was founded in 1964 and is headquartered in New Taipei City, Taiwan.
Show more...
CEO
Mr. Chung-Hsin Huang
Country
TW
ISIN
TW0001762003

Listings